Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radioembolization”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06178198
What this trial is testing

Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 30
Not applicableActive Not RecruitingNCT04390724
What this trial is testing

Optimizing Y90 Therapy for Radiation Lobectomy

Who this might be right for
HCCResectionTransplant+2 more
Northwestern University 104
Not applicableWithdrawnNCT03300401
What this trial is testing

Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization

Who this might be right for
Hepatocellular Carcinoma
University of Southern California
Testing effectiveness (Phase 2)Looking for participantsNCT07530172
What this trial is testing

Radioembolization Versus External Radiation Therapy

Who this might be right for
Heptocellular Cancer
Henry Ford Health System 146
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07511504
What this trial is testing

Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanced Hepatocellular Carcinoma

Who this might be right for
Locally Advanced Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8+1 more
OHSU Knight Cancer Institute 40
Not applicableStudy completedNCT04926376
What this trial is testing

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Hepatocellular Carcinoma Non-resectableMetastatic Colorectal CancerLiver Cancer
ABK Biomedical 8
Testing effectiveness (Phase 2)Study completedNCT03379844
What this trial is testing

HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectable
UMC Utrecht 30
Not applicableLooking for participantsNCT06979219
What this trial is testing

Streamlining Radioembolization for Small HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Seoul National University Hospital 146
Testing effectiveness (Phase 2)UnknownNCT05227482
What this trial is testing

Accurate Dosimetry and Biomarkers Improve Survival in HCC Patients Treated With Resin 90 Yttrium (90Y)-Microspheres

Who this might be right for
HCC
IRCCS Azienda Ospedaliero-Universitaria di Bologna 150
Testing effectiveness (Phase 2)Looking for participantsNCT06642220
What this trial is testing

Ablative Radioembolization of Renal Cell Carcinoma Trial

Who this might be right for
Renal Cell Carcinoma (RCC)Radioembolization
Derek W. Cool 16
Testing effectiveness (Phase 2)WithdrawnNCT03307603
What this trial is testing

Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02936388
What this trial is testing

Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis

Who this might be right for
Uveal Melanoma
Charite University, Berlin, Germany 108
Not applicableLooking for participantsNCT07476651
What this trial is testing

Scout Dose of Resin Microspheres

Who this might be right for
RadioembolizationHepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (ICC)+1 more
Seoul National University Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07657273
What this trial is testing

Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 20
Large-scale testing (Phase 3)WithdrawnNCT02004210
What this trial is testing

Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital
Testing effectiveness (Phase 2)WithdrawnNCT06902246
What this trial is testing

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma
University of Miami
Not applicableEnded earlyNCT03203837
What this trial is testing

Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®

Who this might be right for
Hepatocellular Carcinoma
Northwestern University 4
Large-scale testing (Phase 3)Ended earlyNCT04777851
What this trial is testing

Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7

Who this might be right for
Carcinoma, Hepatocellular
Translational Research in Oncology 45
Not applicableLooking for participantsNCT07252323
What this trial is testing

A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE)

Who this might be right for
CarcinomaHepatocellular Carcinoma
Yonsei University 48
Not applicableEnded earlyNCT01290523
What this trial is testing

Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of California, San Francisco 14
Next Page